Home › Cancer (all types) › Iowa › Cedar Rapids
Cancer (all types) clinical trials in Cedar Rapids, IA
15 studies for Cancer (all types) are looking for participants at sites in and around Cedar Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- University of Iowa Health, Iowa City · 25 mi away
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
- The State University of Iowa, Iowa City · 25 mi away
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
RecruitingPhase 1/2
- University of Iowa Hospitals ( Site 4017), Iowa City · 25 mi away
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RecruitingPhase 3
- Holden Comprehensive Cancer Center, Iowa City · 25 mi away
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
RecruitingPhase 1/2
- University of Iowa Health Care Holden Comprehensive Cancer Center ( Site 3017), Iowa City · 25 mi away
Collection of Tissue Samples for Cancer Research
RecruitingObservational study
- University of Iowa, Iowa City · 25 mi away
Lurbinectedin in FET-Fused Tumors
RecruitingPhase 1/2
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi away
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi away
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi away
A Study of ASP1002 in Adults for Treatment of Solid Tumors
RecruitingPhase 1
- University of Iowa Hospitals, Iowa City · 25 mi away
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- University of Iowa, Iowa City · 25 mi away
Molecular Genetics Studies of Cancer Patients and Their Relatives
RecruitingObservational studyHealthy volunteers welcome
- Mercy Hospital, Cedar Rapids
GEMINI-NSCLC: NSCLC Biomarker Study
RecruitingObservational study
- University of Iowa, Iowa City · 25 mi away
Beat Childhood Cancer Specimen Banking and Data Registry
RecruitingObservational studyHealthy volunteers welcome
- University of Iowa, Iowa City · 25 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Iowa City · 25 mi away
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX121 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Durham, NC58 studies
- Washington, DC58 studies
- Chicago, IL51 studies
- Seattle, WA49 studies
- Atlanta, GA49 studies
- Arlington, VA48 studies
Other studies in Cedar Rapids
- Non-Small Cell Lung Cancer20 studies
- Breast Cancer17 studies
- Acute Myeloid Leukemia16 studies
- Multiple Myeloma15 studies
- Lung Cancer14 studies
- Colorectal Cancer13 studies
- Prostate Cancer12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Melanoma10 studies
- Stroke10 studies
- Metastatic Cancer9 studies
- Endometrial Cancer9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.